Reinhardt has previously served in senior management level roles at other notable medical technology companies including Ethicon Endosurgery, Boston Scientific/Scimed, CR Bard and St. Jude Medical.

Reinhardt noted, This is truly a unique position that affords me the opportunity to quickly apply my experience in structural heart disease, cardiac arrhythmias and cryotherapy to the existing ATS portfolio of products. I’m excited to be working within such a high performing organization and look forward to making my contribution.

Michael Dale, chairman, president and chief executive officer stated, Michael’s background and combined professional experiences bring both a demonstrated record of global marketing leadership as well as clinical and technical knowledge directly relevant to ATS’s core businesses. Dale went on to add, We are gratified that our reputation and demonstrated performance continues to attract top talent to the organization.